What is the current valuation of the Medical Devices Reimbursement Market?

The market valuation was 549.79 USD Billion in 2024. Read More

What is the projected market size for the Medical Devices Reimbursement Market by 2035?

The market is projected to reach 1950.76 USD Billion by 2035. Read More

What is the expected CAGR for the Medical Devices Reimbursement Market from 2025 to 2035?

The expected CAGR during the forecast period is 12.2%. Read More

Which companies are considered key players in the Medical Devices Reimbursement Market?

Key players include Medtronic, Johnson & Johnson, Abbott Laboratories, and Boston Scientific. Read More

What are the main segments of the Medical Devices Reimbursement Market?

The main segments include Diagnostic Devices, Surgical Devices, and Therapeutic Devices. Read More

How much revenue did Diagnostic Devices generate in 2024?

Diagnostic Devices generated approximately 109.96 USD Billion in 2024. Read More

What is the revenue projection for Surgical Devices by 2035?

Surgical Devices are projected to generate around 590.0 USD Billion by 2035. Read More

What are the payer types in the Medical Devices Reimbursement Market?

Payer types include Private Insurance, Public Insurance, and Out of Pocket. Read More

What is the expected revenue from Public Insurance by 2035?

Public Insurance is expected to generate approximately 950.0 USD Billion by 2035. Read More

Which provider types are involved in the Medical Devices Reimbursement Market?

Provider types include Hospitals, Clinics, and Home Healthcare. Read More

Medical Devices Reimbursement Market

ID: MRFR/MED/10860-HCR

200 Pages

Vikita Thakur

Last Updated: June 26, 2026

Medical Devices Reimbursement Market Research Report: Size, Share, Trend Analysis By Medical Device Type (Diagnostic Devices, Surgical Devices, Therapeutic Devices), By Payer Type (Private Insurance, Public Insurance, Out of Pocket), By Reimbursement Model (Fee-for-Service, Capitation, Bundled Payments), By Provider Type (Hospitals, Clinics, Home Healthcare) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Medical Devices Reimbursement Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)12.2%

2024 Market Size$ 549.79 Billion

2025 Market Size$ 616.88 Billion

2035 Market Size$ 1,950.76 Billion

Key Players

Companies such as Medtronic

Johnson & Johnson

Abbott Laboratories

Boston Scientific

Stryker Corporation

B. Braun Melsungen AG

Trends

Increased Focus on Value-Based Reimbursement
Integration of Digital Health Technologies
Regulatory Adaptations and Compliance

Opportunities

Expansion of Health Insurance Coverage
Growing Emphasis on Patient-Centric Care
Technological Advancements in Medical Devices

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Type (USD Billion) | |
  1. 4.1.1 Diagnostic Devices | |
  2. 4.1.2 Surgical Devices | |
  3. 4.1.3 Therapeutic Devices |
2. 4.2 Healthcare, BY Payer Type (USD Billion) | |
  1. 4.2.1 Private Insurance | |
  2. 4.2.2 Public Insurance | |
  3. 4.2.3 Out of Pocket |
3. 4.3 Healthcare, BY Reimbursement Model (USD Billion) | |
  1. 4.3.1 Fee-for-Service | |
  2. 4.3.2 Capitation | |
  3. 4.3.3 Bundled Payments |
4. 4.4 Healthcare, BY Provider Type (USD Billion) | |
  1. 4.4.1 Hospitals | |
  2. 4.4.2 Clinics | |
  3. 4.4.3 Home Healthcare |
5. 4.5 Healthcare, BY Region (USD Billion) | |
  1. 4.5.1 North America | | |
    1. 4.5.1.1 US | | |
    2. 4.5.1.2 Canada | |
  2. 4.5.2 Europe | | |
    1. 4.5.2.1 Germany | | |
    2. 4.5.2.2 UK | | |
    3. 4.5.2.3 France | | |
    4. 4.5.2.4 Russia | | |
    5. 4.5.2.5 Italy | | |
    6. 4.5.2.6 Spain | | |
    7. 4.5.2.7 Rest of Europe | |
  3. 4.5.3 APAC | | |
    1. 4.5.3.1 China | | |
    2. 4.5.3.2 India | | |
    3. 4.5.3.3 Japan | | |
    4. 4.5.3.4 South Korea | | |
    5. 4.5.3.5 Malaysia | | |
    6. 4.5.3.6 Thailand | | |
    7. 4.5.3.7 Indonesia | | |
    8. 4.5.3.8 Rest of APAC | |
  4. 4.5.4 South America | | |
    1. 4.5.4.1 Brazil | | |
    2. 4.5.4.2 Mexico | | |
    3. 4.5.4.3 Argentina | | |
    4. 4.5.4.4 Rest of South America | |
  5. 4.5.5 MEA | | |
    1. 4.5.5.1 GCC Countries | | |
    2. 4.5.5.2 South Africa | | |
    3. 4.5.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Medtronic (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Johnson & Johnson (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Abbott Laboratories (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Boston Scientific (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Stryker Corporation (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 B. Braun Melsungen AG (DE) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Siemens Healthineers (DE) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Philips Healthcare (NL) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 GE Healthcare (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY TYPE |
7. 6.4 US MARKET ANALYSIS BY PAYER TYPE |
8. 6.5 US MARKET ANALYSIS BY REIMBURSEMENT MODEL |
9. 6.6 US MARKET ANALYSIS BY PROVIDER TYPE |
10. 6.7 CANADA MARKET ANALYSIS BY TYPE |
11. 6.8 CANADA MARKET ANALYSIS BY PAYER TYPE |
12. 6.9 CANADA MARKET ANALYSIS BY REIMBURSEMENT MODEL |
13. 6.10 CANADA MARKET ANALYSIS BY PROVIDER TYPE |
14. 6.11 EUROPE MARKET ANALYSIS |
15. 6.12 GERMANY MARKET ANALYSIS BY TYPE |
16. 6.13 GERMANY MARKET ANALYSIS BY PAYER TYPE |
17. 6.14 GERMANY MARKET ANALYSIS BY REIMBURSEMENT MODEL |
18. 6.15 GERMANY MARKET ANALYSIS BY PROVIDER TYPE |
19. 6.16 UK MARKET ANALYSIS BY TYPE |
20. 6.17 UK MARKET ANALYSIS BY PAYER TYPE |
21. 6.18 UK MARKET ANALYSIS BY REIMBURSEMENT MODEL |
22. 6.19 UK MARKET ANALYSIS BY PROVIDER TYPE |
23. 6.20 FRANCE MARKET ANALYSIS BY TYPE |
24. 6.21 FRANCE MARKET ANALYSIS BY PAYER TYPE |
25. 6.22 FRANCE MARKET ANALYSIS BY REIMBURSEMENT MODEL |
26. 6.23 FRANCE MARKET ANALYSIS BY PROVIDER TYPE |
27. 6.24 RUSSIA MARKET ANALYSIS BY TYPE |
28. 6.25 RUSSIA MARKET ANALYSIS BY PAYER TYPE |
29. 6.26 RUSSIA MARKET ANALYSIS BY REIMBURSEMENT MODEL |
30. 6.27 RUSSIA MARKET ANALYSIS BY PROVIDER TYPE |
31. 6.28 ITALY MARKET ANALYSIS BY TYPE |
32. 6.29 ITALY MARKET ANALYSIS BY PAYER TYPE |
33. 6.30 ITALY MARKET ANALYSIS BY REIMBURSEMENT MODEL |
34. 6.31 ITALY MARKET ANALYSIS BY PROVIDER TYPE |
35. 6.32 SPAIN MARKET ANALYSIS BY TYPE |
36. 6.33 SPAIN MARKET ANALYSIS BY PAYER TYPE |
37. 6.34 SPAIN MARKET ANALYSIS BY REIMBURSEMENT MODEL |
38. 6.35 SPAIN MARKET ANALYSIS BY PROVIDER TYPE |
39. 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE |
40. 6.37 REST OF EUROPE MARKET ANALYSIS BY PAYER TYPE |
41. 6.38 REST OF EUROPE MARKET ANALYSIS BY REIMBURSEMENT MODEL |
42. 6.39 REST OF EUROPE MARKET ANALYSIS BY PROVIDER TYPE |
43. 6.40 APAC MARKET ANALYSIS |
44. 6.41 CHINA MARKET ANALYSIS BY TYPE |
45. 6.42 CHINA MARKET ANALYSIS BY PAYER TYPE |
46. 6.43 CHINA MARKET ANALYSIS BY REIMBURSEMENT MODEL |
47. 6.44 CHINA MARKET ANALYSIS BY PROVIDER TYPE |
48. 6.45 INDIA MARKET ANALYSIS BY TYPE |
49. 6.46 INDIA MARKET ANALYSIS BY PAYER TYPE |
50. 6.47 INDIA MARKET ANALYSIS BY REIMBURSEMENT MODEL |
51. 6.48 INDIA MARKET ANALYSIS BY PROVIDER TYPE |
52. 6.49 JAPAN MARKET ANALYSIS BY TYPE |
53. 6.50 JAPAN MARKET ANALYSIS BY PAYER TYPE |
54. 6.51 JAPAN MARKET ANALYSIS BY REIMBURSEMENT MODEL |
55. 6.52 JAPAN MARKET ANALYSIS BY PROVIDER TYPE |
56. 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE |
57. 6.54 SOUTH KOREA MARKET ANALYSIS BY PAYER TYPE |
58. 6.55 SOUTH KOREA MARKET ANALYSIS BY REIMBURSEMENT MODEL |
59. 6.56 SOUTH KOREA MARKET ANALYSIS BY PROVIDER TYPE |
60. 6.57 MALAYSIA MARKET ANALYSIS BY TYPE |
61. 6.58 MALAYSIA MARKET ANALYSIS BY PAYER TYPE |
62. 6.59 MALAYSIA MARKET ANALYSIS BY REIMBURSEMENT MODEL |
63. 6.60 MALAYSIA MARKET ANALYSIS BY PROVIDER TYPE |
64. 6.61 THAILAND MARKET ANALYSIS BY TYPE |
65. 6.62 THAILAND MARKET ANALYSIS BY PAYER TYPE |
66. 6.63 THAILAND MARKET ANALYSIS BY REIMBURSEMENT MODEL |
67. 6.64 THAILAND MARKET ANALYSIS BY PROVIDER TYPE |
68. 6.65 INDONESIA MARKET ANALYSIS BY TYPE |
69. 6.66 INDONESIA MARKET ANALYSIS BY PAYER TYPE |
70. 6.67 INDONESIA MARKET ANALYSIS BY REIMBURSEMENT MODEL |
71. 6.68 INDONESIA MARKET ANALYSIS BY PROVIDER TYPE |
72. 6.69 REST OF APAC MARKET ANALYSIS BY TYPE |
73. 6.70 REST OF APAC MARKET ANALYSIS BY PAYER TYPE |
74. 6.71 REST OF APAC MARKET ANALYSIS BY REIMBURSEMENT MODEL |
75. 6.72 REST OF APAC MARKET ANALYSIS BY PROVIDER TYPE |
76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
77. 6.74 BRAZIL MARKET ANALYSIS BY TYPE |
78. 6.75 BRAZIL MARKET ANALYSIS BY PAYER TYPE |
79. 6.76 BRAZIL MARKET ANALYSIS BY REIMBURSEMENT MODEL |
80. 6.77 BRAZIL MARKET ANALYSIS BY PROVIDER TYPE |
81. 6.78 MEXICO MARKET ANALYSIS BY TYPE |
82. 6.79 MEXICO MARKET ANALYSIS BY PAYER TYPE |
83. 6.80 MEXICO MARKET ANALYSIS BY REIMBURSEMENT MODEL |
84. 6.81 MEXICO MARKET ANALYSIS BY PROVIDER TYPE |
85. 6.82 ARGENTINA MARKET ANALYSIS BY TYPE |
86. 6.83 ARGENTINA MARKET ANALYSIS BY PAYER TYPE |
87. 6.84 ARGENTINA MARKET ANALYSIS BY REIMBURSEMENT MODEL |
88. 6.85 ARGENTINA MARKET ANALYSIS BY PROVIDER TYPE |
89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE |
90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY PAYER TYPE |
91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY REIMBURSEMENT MODEL |
92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROVIDER TYPE |
93. 6.90 MEA MARKET ANALYSIS |
94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE |
95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY PAYER TYPE |
96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY REIMBURSEMENT MODEL |
97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY PROVIDER TYPE |
98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE |
99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY PAYER TYPE |
100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY REIMBURSEMENT MODEL |
101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY PROVIDER TYPE |
102. 6.99 REST OF MEA MARKET ANALYSIS BY TYPE |
103. 6.100 REST OF MEA MARKET ANALYSIS BY PAYER TYPE |
104. 6.101 REST OF MEA MARKET ANALYSIS BY REIMBURSEMENT MODEL |
105. 6.102 REST OF MEA MARKET ANALYSIS BY PROVIDER TYPE |
106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
107. 6.104 RESEARCH PROCESS OF MRFR |
108. 6.105 DRO ANALYSIS OF HEALTHCARE |
109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
112. 6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE) |
113. 6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion) |
114. 6.111 HEALTHCARE, BY PAYER TYPE, 2024 (% SHARE) |
115. 6.112 HEALTHCARE, BY PAYER TYPE, 2024 TO 2035 (USD Billion) |
116. 6.113 HEALTHCARE, BY REIMBURSEMENT MODEL, 2024 (% SHARE) |
117. 6.114 HEALTHCARE, BY REIMBURSEMENT MODEL, 2024 TO 2035 (USD Billion) |
118. 6.115 HEALTHCARE, BY PROVIDER TYPE, 2024 (% SHARE) |
119. 6.116 HEALTHCARE, BY PROVIDER TYPE, 2024 TO 2035 (USD Billion) |
120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
121. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY TYPE, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY PAYER TYPE, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY PROVIDER TYPE, 2025-2035 (USD Billion) |
151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
152. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Medical Devices Reimbursement Market Segmentation

Medical Devices Reimbursement Market By Type (USD Billion, 2025-2035)

Diagnostic Devices
Surgical Devices
Therapeutic Devices

Medical Devices Reimbursement Market By Payer Type (USD Billion, 2025-2035)

Private Insurance
Public Insurance
Out of Pocket

Medical Devices Reimbursement Market By Reimbursement Model (USD Billion, 2025-2035)

Fee-for-Medical Devices Reimbursement Market
Capitation
Bundled Payments

Medical Devices Reimbursement Market By Provider Type (USD Billion, 2025-2035)

Hospitals
Clinics
Home Medical Devices Reimbursement Market

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”